* 本报告来自网络,如有侵权请联系删除
2019年第二季度健康产业报告
收藏
纠错
价格免费
详情描述
H1'19 saw a first half record in both deals and dollars: The amount invested in healthcare companies globally rose to $26.9B in H119 compared to $26.5B in H1'18.Over the same period, deals increased from 2,223 to 2,258. The second quarter saw funding decline in Asia,North America, and Europe:Healthcare funding to Asia-based companies dropped 39% in Q2'19, while NorthAmerica and Europe funding levels were also down. Digital health funding is on the rise for the second straight quarter: Total digitalhealth funding was $3.5B, up 23% versus Q119.There were 371 digital health dealscompared to 354 in the first quarter. Massachusetts takes over as the #2 US state for digital health deals: Massachusettsbased companies raised 29 rounds in Q2'19,taking over the number 2 spot from NewYork (24) but still far behind California (85 deals). There are 38 VC-backed digital health unicorns worth a combined $90.7B: Thecohort's total valuation in 2019 continues to grow as a result of continued mega-rounds to existing unicorns,such as Tempus and Doctolib,among others. Q2'19 clinical trial deals went to startups expediting patient recruitment andenrollment: From recruitment marketplaces to provider tools, we continue to seeincreased offerings for the healthcare industry to revamp this area. Hemp/CBD startups take a record 25% of cannabis funding: In Q2'19,27 (25%) of the107 cannabis deals were for startups with a hemp and/or CBD business component.That compares to only 11 (15%) of the 73 deals in Q2'18. Al in healthcare startups and mental health & wellness startups reach funding highsin Q2'19: Healthcare Al companies raised $864M in the second quarter, led by a$200M round to Tempus in May. Mental health & wellness companies raised $321Macross 26 deals, with large rounds going to Quartet and Talkspace. The application of emerging technologies in genomics is picking up: New platformssuch as telegenomics and blockchain-enabled networks are becoming more prevalent. Digital therapeutics continue to provide new avenues of treatment for chronic disease management: This quarter has seen deals going to startups pursuing morespecific health issues such as joint pain and respiratory disorders. First Round Capital and Jumpstart Foundry participated in the most digital healthrounds in Q219: Overlapping targets for the top investors included CureFit and SigTuple. 0ther leading digital health investors included Chiratae Ventures, Civilizationventures,and Perceptive Advisers. SubjectWell provides patient recruitment servicesfor trial sites, pharmaceutical companies, andclinical research organizations (CROs). lt works toaccelerate patient enrollment for trials through itsmarketplace of potential patients. lt provides this service through educationcampaigns and telephone-based prescreening.Clients pay for this service only when patientsrandomize into trials. select investors Geekdom Fund, Healthy Ventures, Windham VenturePartners 【更多详情,请下载:2019年第二季度健康产业报告】
报告预览
*本报告来自网络,如有侵权请联系删除